Year founded
-
Country of origin
Netherlands
HQ country
Netherlands
Total deal value
Average deal value
Company industry
- Medical & Biotech
M&A expertise
- -
Industry expertise
- Medical & Biotech
Dezima Pharma B.V. develops novel compounds for treatment of cardiovascular disease related to dyslipidemia. The company is based in Naarden, the Netherlands.
Latest deals
Amgen acquires Dezima Pharma from Forbion
16-09-2015
€ 1.38 billion